Back to BROWN ADVISORY INC BROWN ADVISORY INC

INTSINTS
Showing 7 of 9 quarters

Position history for BROWN ADVISORY INCBROWN ADVISORY INC's holdings in INTENSITY THERAPEUTICS INC

No. Brown Advisory exited its INTS (Intensity Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 130,000 shares worth $53,326. Brown Advisory first reported INTS in Q1 2024 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$565,776

Total Shares Change

-148,109

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$5.88
0
2025-Q4
Decreased
130,000
-0.1%
$53,3260.0%$10.25
0
2025-Q3
Unchanged
130,072
0.0%
$31,5680.0%$6.08
0
2025-Q2
Unchanged
130,072
0.0%
$39,9320.0%$7.68
0
2025-Q1
Unchanged
130,072
0.0%
$256,2420.0%$49.25
0
2024-Q4
Decreased
130,072
-12.2%
$228,9270.0%$44.00
0
2024-Q3
Decreased
148,109
-6.0%
$565,7760.0%$95.50
0

Other major holders of INTS: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used